CollaRx® Gentamicin Surgical Implant US
According to the latest (2005) statistics published by the Pennsylvania Health Care Cost Containment Council (PHC4), one of the few US States mandated to collect such data, patients that contracted a surgical site infection spent an average of 14.5 days in hospital at an average hospital charge of $132,110 compared to 4.7 days and $33,267 for patients that had no hospital-acquired infection. The same official report states that "surgery performed on the large and small intestines represented the largest percentage of surgical site infections at 9.0% followed closely by surgery for blockages in blood vessels, including blood vessels of the heart, which accounted for 8.9%".
Innocoll's CollaRx® Gentamicin Surgical Implant is currently in phase III clinical development in the US for the prevention of surgical site infections (SSIs) in patients at risk of infection.
| Download Cardiac Training Video |
| Download Colorectal Training Video |